Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04383483
Other study ID # BYIEAH-202005
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 15, 2020
Est. completion date February 28, 2022

Study information

Verified date March 2021
Source Bursa Yüksek Ihtisas Education and Research Hospital
Contact Ali Asan, MD
Phone +905332401067
Email draasan@yahoo.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In the course of COVID disease, some patients need intensive care treatment. We aim to find an answer to the question of whether the patient's CRP, ferritin, D-dimer, Oxygen Saturation, lymphocyte count, and body mass index can be used as a criterion for admitting patients with COVID to the intensive see unit.


Description:

It is aimed to determine the patients who are above the threshold value to be determined according to this scoring result. Identifying patients who may need intensive care and following them closely will positively affect patient prognosis.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date February 28, 2022
Est. primary completion date January 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: Patients admitted to the intensive care unit with the diagnosis of COVID Exclusion Criteria: <18 years patients

Study Design


Related Conditions & MeSH terms


Intervention

Other:
COVICU
COVICU

Locations

Country Name City State
Turkey Bursa Yüksek Ihtisas Training and Research Hospital Bursa Yildirim

Sponsors (1)

Lead Sponsor Collaborator
Bursa Yüksek Ihtisas Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary COVICU score With this scoring, identifying patients who may need intensive care early and following them closely will have a positive effect on patient prognosis. 1 week
Primary Values Minimum and maximum values will be determined at the end of the study. Higher scores mean a worse outcome 1 week
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04348370 - BCG Vaccine for Health Care Workers as Defense Against COVID 19 Phase 4
Terminated NCT04369989 - Observational Study of COVID-19 Treatment Efficacy